ClinicalTrials.Veeva

Menu

Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients

National Institute of Allergy and Infectious Diseases (NIAID) logo

National Institute of Allergy and Infectious Diseases (NIAID)

Status

Completed

Conditions

Kidney Transplantation

Treatments

Procedure: Kidney transplantation

Study type

Observational

Funder types

NIH

Identifiers

NCT00308802
DAIT CTOT-01

Details and patient eligibility

About

The purpose of this study is to test noninvasive methods to monitor the health and condition of new kidneys in people who have received kidney transplants.

Full description

Innovations in kidney transplantation have improved short-term outcomes for transplant patients. However, organ rejection remains as an important threat to the long-term survival of the transplanted organ. If clinicians could better monitor the condition of the organ after transplantation, they may be able to improve the chance of graft survival. Noninvasive ways to monitor the condition of the transplanted organ need to be developed and tested. This observational study will investigate whether certain blood and urine tests are useful in monitoring the health of transplanted kidneys.

This trial will involve 14 post-transplant study visits over the course of 2 years. A physical exam, medication history, adverse events assessment, and blood and urine collection will occur at all visits. Kidney biopsies will occur at study entry prior to transplantation and at Month 6, in adult participants only. Protocol biopsies are optional in the pediatric substudy group. Additional visits may be required if organ rejection is suspected.

Enrollment

280 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Candidate for deceased donor or living donor kidney transplant
  • Negative Crossmatch
  • Parent or guardian willing to provide informed consent, if applicable

Exclusion criteria

  • Clinically significant liver disease
  • Other illnesses that, in the opinion of the investigator, may interfere with the study
  • Recipient of multiple organ transplants
  • Inability or unwillingness to comply with the study protocol

Trial contacts and locations

9

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems